| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |